Actionable insights straight to your inbox

Equities logo

Epizyme Gets Accelerated FDA Approval of Epithelioid Sarcoma Drug

First epithelioid sarcoma treatment approved by the FDA.
Shares of Pharmacyclics, Inc. ($PCYC) are on the run Tuesday after and Independent Data Monitoring Committee said that a Phase III trial of Imbruvica (ibrutinib) should be stopped early because it